Macropore Inc. IR-Pages
MacroPore Biosurgery Inc. english
MacroPore Biosurgery: Second Quarter Results on 08/14/03
Corporate-news announcement sent by DGAP.
The sender is solely responsible for the contents of this announcement.
——————————————————————————–
MacroPore Biosurgery to Announce Second Quarter Results
on August 14, 2003
– Chief Officers to Conduct Conference Call Webcast Live –
San Diego, CA / Königstein/Ts., August 4, 2003. MacroPore Biosurgery, Inc.
(Frankfurt: XMP) today announced that it will release its second quarter
financial results on Thursday, August 14, 2003 at approximately 4:00 p.m.
Central European Summer Time (CEST) / 7:00 a.m. Pacific Standard Time (PST). The
announcement will be followed by a conference call at 4:30 (CEST) / 7:30 a.m.
(PST) hosted by Christopher J. Calhoun, President and Chief Executive Officer,
Ari E. Bizimis, Chief Financial Officer, and Marc H. Hedrick, MD, Chief
Scientific Officer.
The conference call will be webcast live and may be accessed on the Investor
Relations section of the Company’s website at http://www.macropore.com. 60
Minutes after terminating the conference call, an archived version of the
webcast will be available at the same website. A telephone replay will also be
available until Saturday, August 18, 2003, 6:00 (CEST) / 9:00 a.m. (PST). To
access the replay, please call from Europe +49 / 69 / 5 89 99 05 68
(PIN: 132034) and from the USA 1-303-590-3060 (PIN: 21012975).
About MacroPore Biosurgery, Inc.:
MacroPore Biosurgery, Inc. is a leader in the design, development, and
production of bioresorbable polymer implants for use in a variety of surgical
applications and is pioneering advancement of regenerative medicine for surgical
therapies using adult stem cells derived from adipose (fat tissue). Some
products designed for use in spine, neurosurgical, and musculoskeletal surgeries
are distributed by Medtronic, while other products designed for soft tissue are
distributed through our direct US sales force and an international distribution
network. MacroPore Biosurgery is traded on the Frankfurt Stock Exchange in
Germany under the symbol ‘XMP’. For further information please visit the web
site www.macropore.com.
Edited and published by:
MacroPore Biosurgery, Inc., Ölmühlweg 33, D-61462 Königstein
Contact:
Ari E. Bizimis, CFO: Ph. +49-6174-2597-0, Fax: +49-6174-2597-25,
abizimis@macropore.com
end of message, (c)DGAP 04.08.2003
——————————————————————————–
WKN: 940682; ISIN: USU553961025; Index: NEMAX 50
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart
041100 Aug 03
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found